A comprehensive view of Hospital / Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
Executive Perspective: AstraZeneca CEO Pascal Soriot defends recent spate of acquisitions, arguing they're vital for future growth; Soriot says the deals aim to create synergy between oncology, vaccines, and respiratory disease products
Published:
April 25, 2024
by FiercePharma
|
Bristol Myers Squibb reports first quarter financial results for 2024
Published:
April 25, 2024
by Bristol-Myers Squibb Co.
|
Par Pharmaceutical expands recall to include seven lots of Treprostinil Injection 20mg/20mL due to the possibility of silicone particulates in the product; affected product is distributed in 20mL multidose vials as sterile solutions in water for injection
Published:
April 23, 2024
by PR Newswire
|
INTERNATIONAL PATENT: THE GENERAL HOSPITAL CORPORATION, MASSACHUSETTS EYE AND EAR INFIRMARY, BANNER HEALTH FILES APPLICATION FOR "COMPOSITIONS AND METHODS USING REELIN IN ALZHEIMER'S DISEASE"
Published:
April 23, 2024
by U.S. Fed News
|
European Commission approves Jannsen's CARVYKTI ciltacabtagene autoleucel cilta-cel for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy; it is the first BCMA-targeted treatment approved by the EC
Published:
April 22, 2024
by Janssen Pharmaceutical Companies
|
Ask us about our Consumer Wellness market view